GLP-1 drugs (exenatide, liraglutide etc), as well as GIP/GLP-1 hybrid peptides (tirzepatide), are clinically approved for diabetes and/or obesity, with GLP-2 based drugs (teduglutide) approved for the treatment of short bowel syndrome
What should a person expect when beginning treatment and over the long term
Unlock your healthiest body yet Promo: $45 first month, $145/month thereafter Access to doctor-prescribed GLP-1s Personal health coaching via video chats and messaging Personalized weight loss plan Insurance concierge to help navigate medication coverage
Glucagon-like peptide 1 receptor agonist (GLP-1 RA): long-term effect on kidney function in patients with type 2 diabetes
Oral semaglutide for the treatment of obesity: a retrospective real-world study
Enteric nervous system The ENS is an independently functioning neural system innervating the entire GI tract and containing two bundles of ganglia: one underneath the epithelial layer of the gut (submucosal plexus) and the other between the smooth muscle layers of the gut (myenteric plexus) 25
